Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?
Sagimet Biosciences Ownership Summary
Sagimet Biosciences is owned by 36.26% institutional investors, 9.81% insiders, and 53.93% retail investors. Blue owl capital lp is the largest institutional shareholder, holding 4.13% of SGMT shares.
SGMT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Sagimet Biosciences | 36.26% | 9.81% | 53.93% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blue owl capital lp | 1.33M | 4.13% | $10.12M |
Baker bros. advisors lp | 953.00K | 2.96% | $7.26M |
Hhlr advisors | 724.80K | 2.25% | $5.52M |
Siren | 724.77K | 2.25% | $5.52M |
Blackrock funding, inc. /de | 483.08K | 1.50% | $3.68M |
Readystate asset management lp | 269.19K | 0.84% | $2.05M |
Raymond james financial | 264.68K | 0.82% | $2.02M |
Millennium management | 160.91K | 0.50% | $524.57K |
Jump financial | 148.35K | 0.46% | $1.13M |
Pfm health sciences, lp | 90.00K | 0.28% | $685.80K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Dumac | 75.00K | 3.59% | $571.50K |
Blue owl capital lp | 1.33M | 3.27% | $10.12M |
Siren | 724.77K | 0.29% | $5.52M |
Fny investment advisers | 86.74K | 0.28% | $660.00K |
Hhlr advisors | 724.80K | 0.18% | $5.52M |
Baker bros. advisors lp | 953.00K | 0.07% | $7.26M |
Readystate asset management lp | 269.19K | 0.06% | $2.05M |
Pfm health sciences, lp | 90.00K | 0.06% | $685.80K |
Silverarc capital management | 37.54K | 0.05% | $286.05K |
Ikarian capital | 11.98K | 0.02% | $91.32K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Readystate asset management lp | 269.19K | 0.06% | 269.19K |
Jump financial | 148.35K | 0.01% | 148.35K |
Hrt financial lp | 69.91K | 0.00% | 69.91K |
Silverarc capital management | 37.54K | 0.05% | 37.54K |
Bailard | 29.03K | 0.01% | 29.03K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nea management company | - | - | -2.00M |
Point72 asset management | - | - | -1.76M |
Alyeska investment group | - | - | -1.19M |
Rock springs capital management lp | - | - | -787.81K |
Pfm health sciences, lp | 90.00K | 0.06% | -559.01K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Readystate asset management lp | 269.19K | 0.06% | 269.19K | $2.05M |
Jump financial | 148.35K | 0.01% | 148.35K | $1.13M |
Hrt financial lp | 69.91K | 0.00% | 69.91K | $532.00K |
Silverarc capital management | 37.54K | 0.05% | 37.54K | $286.05K |
Bailard | 29.03K | 0.01% | 29.03K | $221.20K |
Sold Out
Holder | Change |
---|---|
Advisor group | -10.00 |
Srs capital advisors | -115.00 |
Ifp advisors | -1.00K |
Pale fire capital se | -10.99K |
Boothbay fund management | -12.52K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 73 | -2.67% | 11,674,800 | -15.26% | 36 | 1.98% | 38 | 15.15% | 11 | -38.89% |
Mar 31, 2025 | 6 | -91.43% | 2,545,717 | -85.38% | 7 | 0.26% | 1 | -96.77% | 1 | -94.74% |
Dec 31, 2024 | 71 | 5.97% | 17,500,774 | -10.97% | 55 | 1.49% | 32 | 39.13% | 19 | -17.39% |
Sep 30, 2024 | 67 | -20.24% | 19,656,790 | -6.06% | 61 | 1.42% | 23 | -46.51% | 23 | 4.55% |
Jun 30, 2024 | 84 | 3.70% | 20,925,652 | -7.45% | 65 | 1.08% | 43 | -34.85% | 22 | 100.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 21, 2025 | Happel David | President & CEO | Sell | $598.12K |
Jul 21, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Sell | $75.61K |
Jul 21, 2025 | Rozek Elizabeth | General Counsel and CCO | Sell | $98.47K |
Jul 23, 2024 | Kemble George | Executive Chairman | Sell | $74.83K |
Jul 19, 2024 | Martins Eduardo Bruno | Chief Medical Officer | Sell | $25.91K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 3 |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q3 | - | 4 |
2024 Q2 | - | - |
SGMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools